Last reviewed · How we verify
Benoral (BENORILATE)
Benoral (generic name: BENORILATE) is a benorilate drug. It is currently in Phase 2 development.
Benoral is thought to work by interacting with a specific biological target, although its exact mechanism of action is currently unknown.
Benoral is a small molecule with an unknown mechanism of action. It is also known by several synonyms, including Benorilate, Benorylate, and Triadol.
-
Baseline phase 2 → approval rate
+15.3pp
Industry-wide phase 2 drugs reach approval ~15.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2031–2034 | — |
| EMA | EU | 2032–2035 | +0.7 yr |
| MHRA | GB | 2032–2035 | +0.7 yr |
| Health Canada | CA | 2032–2036 | +0.9 yr |
| TGA | AU | 2032–2036 | +1.2 yr |
| PMDA | JP | 2032–2036 | +1.5 yr |
| NMPA | CN | 2033–2037 | +2.3 yr |
| MFDS | KR | 2032–2036 | +1.4 yr |
| CDSCO | IN | 2032–2037 | +1.8 yr |
| ANVISA | BR | 2033–2037 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | BENORILATE |
|---|---|
| Drug class | benorilate |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 2 |
Mechanism of action
Imagine your body's cells are like locks, and benoral is a key that fits into one of those locks. When benoral binds to its target, it can either block or enhance the activity of that target, leading to changes in the way the body functions. However, without more information, it's difficult to say exactly how benoral works or what effects it might have on the body.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Benoral CI brief — competitive landscape report
- Benoral updates RSS · CI watch RSS
Frequently asked questions about Benoral
What is Benoral?
How does Benoral work?
What is the generic name of Benoral?
What drug class is Benoral in?
What development phase is Benoral in?
Related
- Drug class: All benorilate drugs
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing